Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study

Author(s):: Schetelig, J.; Hoek, J.; Stilgenbauer, S.; Middeke, J.M.; Andersen, N.S.; Fox, C.P.; Lenhoff, S.; Volin, L.; Shimoni, A.; Schroyens, W.; Gelder, M. van; Bunjes, D.; Biezen, A. van; Baldauf, H.; Wreede, L.C. de (0000-0002-7667-9369); Tournilhac, O.; Kroger, N.; Yakoub-Agha, I.; Dreger, P.

Published: 2020
Publication type: Article / Letter to editor

Date issued: 2020-08-16
Language: English
Publisher: NATURE PUBLISHING GROUP
Is part of: Bone Marrow Transplantation (2020), Vol. 56, p. 692-695
hdl: 1887/3182209
doi: 10.1038/s41409-020-01013-y
URL: https://www.nature.com/articles/s41409-020-01013-y